Works matching IS 1021335X AND DT 2022 AND VI 47 AND IP 1
Results: 21
FGD5-AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β-catenin signaling pathway via miR-577.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Metabolism-related pharmacokinetic drug-drug interactions with poly (ADP-ribose) polymerase inhibitors.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Characterization of morphological alterations in micropapillary adenocarcinoma of the lung using an established cell line.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
SLC7A5 is linked to increased expression of genes related to proliferation and hypoxia in estrogen-receptor-positive breast cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Contributing factors common to COVID-19 and gastrointestinal cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
β-glucan vaccine adjuvant approach for cancer treatment through immune enhancement (B-VACCIEN) in specific immunocompromised populations.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
New insights into Epstein-Barr virus-associated tumors: Exosomes.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
MicroRNA-190b expression predicts a good prognosis and attenuates the malignant progression of pancreatic cancer by targeting MEF2C and TCF4.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
PIK3CA mutation affects the proliferation of colorectal cancer cells through the PI3K-MEK/PDK1-GPT2 pathway.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
EGF repeats of epidermal growth factor-like domain 7 promote endothelial cell activation and tumor escape from the immune system.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Glucose transporter-1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
JAK2/STAT3-mediated dose-dependent cytostatic and cytotoxic effects of sesquiterpene lactones from Gymnanthemum extensum on A549 human lung carcinoma cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Contrasting functions of the epithelial-stromal interaction 1 gene, in human oral and lung squamous cell cancers.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Diosmin in combination with naringenin enhances apoptosis in colon cancer cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Androgen deprivation-induced OPHN1 amplification promotes castration-resistant prostate cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
miR-506 functions as a tumor suppressor in glioma by targeting STAT3.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article